Novel Blood, Tissue and Imaging Biomarkers for Pancreatic Cancer

Byeon, Sooin

Access status:

Open Access

Field	Value	Language
dc.contributor.author	Byeon, Sooin
dc.date.accessioned	2024-07-10T05:00:20Z
dc.date.available	2024-07-10T05:00:20Z
dc.date.issued	2024	en_AU
dc.identifier.uri	https://hdl.handle.net/2123/32773
dc.description	Includes publication
dc.description.abstract	Pancreatic ductal adenocarcinoma (PDAC) is one of the most common types of pancreatic cancer. However, it has one of the most dismal survival outcomes of all major cancers and is projected to become the second most common cause of cancer-related deaths by 2030. Due to its asymptomatic feature and poor prognostic outcomes for most patients, identifying biomarkers for early diagnosis, prognosis, and prediction of treatment response could lead to the development of optimised treatment plans for PDAC patients. This thesis focused on identifying changes in biometals, proteins, and imaging parameters as potential biomarkers and drug targets with the aim to develop novel optimised treatment regimens for PDAC patients.	en_AU
dc.language.iso	en	en_AU
dc.subject	pancreatic ductal adenocarcinoma	en_AU
dc.subject	pancreatic cancer	en_AU
dc.subject	biomarker	en_AU
dc.subject	metal	en_AU
dc.subject	protein	en_AU
dc.subject	PET	en_AU
dc.title	Novel Blood, Tissue and Imaging Biomarkers for Pancreatic Cancer	en_AU
dc.type	Thesis
dc.type.thesis	Masters by Research	en_AU
dc.rights.other	The author retains copyright of this thesis. It may only be used for the purposes of research and study. It must not be used for any other purposes and may not be transmitted or shared with others without prior permission.	en_AU
usyd.faculty	SeS faculties schools::Faculty of Medicine and Health::Northern Clinical School	en_AU
usyd.degree	Master of Philosophy M.Phil	en_AU
usyd.awardinginst	The University of Sydney	en_AU
usyd.advisor	SAHNI, SUMIT
usyd.include.pub	Yes	en_AU